|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.
Correspondence to: Peter Dicpinigaitis, MD, FCCP, Albert Einstein Hospital, 1825 Eastchester Rd, Bronx, NY 10461; e-mail: pdicpinigaitis{at}pol.net
| Abstract |
|---|
|
|
|---|
Design: Cross-sectional comparison.
Setting: Academic medical center.
Participants: Twenty healthy, male current-smokers (mean [± SEM] age, 32.2 ± 1.2 years).
Measurements: Subjects underwent baseline spirometry followed by capsaicin cough challenge testing, which involved the inhalation of capsaicin in ascending, doubling concentrations until the concentrations inducing two or more coughs (C2) and those inducing five or more coughs (C5) were reached. The data were compared to those from a group of 50 healthy, male nonsmokers who had undergone identical cough challenge testing.
Results: The two groups did not differ in terms of age or baseline pulmonary function. Cough sensitivity was significantly diminished in the current-smokers compared to control subjects. The mean (± SEM) log C2 values in smokers and nonsmokers were 1.26 ± 0.13 and 0.81 ± 0.08, respectively (p = 0.004). The mean log C5 values in smokers and nonsmokers were 2.03 ± 0.10 and 1.20 ± 0.08, respectively (p < 0.000001).
Conclusions: Cough reflex sensitivity is significantly diminished in young, healthy, male current-smokers compared to a similar population of nonsmokers. The mechanism of cough suppression in smokers remains speculative but may involve long-term tobacco smoke-induced desensitization of the cough receptors within the airway epithelium.
Key Words: capsaicin cough pulmonary function tests smoking
| Introduction |
|---|
|
|
|---|
The cough reflex serves a protective function by preventing foreign material from entering the respiratory tract and by facilitating the expulsion of mucus from the airways. To date, relatively little attention has been paid to the effect of cigarette smoking on cough reflex sensitivity. Animal studies have suggested that long-term exposure to tobacco smoke enhances the sensitivity of the cough reflex, perhaps by stimulating tachykinin synthesis and release within the airways.2 3 4 However, two small studies in humans have demonstrated higher cough thresholds (ie, diminished cough sensitivity) in smokers compared to nonsmokers.5 6
To further investigate the effect of long-term cigarette smoking on cough reflex sensitivity, we prospectively performed capsaicin cough challenge testing in a group of healthy, male current-smokers, and compared the data with those of healthy, male nonsmokers. The tussive agent capsaicin has been shown in humans to induce cough in a safe, reproducible, and dose-dependent manner,7 thereby rendering it an excellent tool for the measurement of cough reflex sensitivity. Unlike previous studies, only subjects of one gender (male) were compared because of the well-documented gender differences in cough reflex sensitivity.8 9
| Materials and Methods |
|---|
|
|
|---|
|
Subjects inhaled single breaths (from FRC to TLC) of capsaicin aerosol administered via a nebulizer (model 646; DeVilbiss Health Care Inc; Somerset, PA) controlled by a dosimeter (KoKo DigiDoser; Pulmonary Data Service Instrumentation Inc; Louisville, CO). The nebulizers used in these studies were modified in two ways. First, an inspiratory flow regulator valve (RIFR; Pulmonary Data Service Instrumentation, Inc) was added, which limited the inspiratory flow rate to 0.5 L/s regardless of inspiratory force, thereby guaranteeing a consistent and reproducible inspiratory effort with each breath. Second, the straw and baffle assembly of each nebulizer was welded in place, thereby eliminating the variations in nebulizer output that occur when these components are detached for washing and then reattached with resulting variable distances between the jet orifice and the straw. After these modifications were performed, the exact output of the nebulizer was determined (characterized nebulizer; Pulmonary Data Service Instrumentation, Inc). The two nebulizers used to perform all studies in subjects and control subjects described herein had an output of 1.007 mL/min. The duration of aerosol delivery was programmed at 1.2 s, thereby providing 0.02 mL per breath. Single breaths of capsaicin aerosol were administered in ascending order, with inhalations of saline solution randomly interspersed to increase challenge blindness, until the concentrations inducing two or more coughs (C2) and five or more coughs (C5) were reached. Breaths were delivered at 1-min intervals. Subjects were unaware that the end point of the study was the number of coughs induced. Cough challenge studies in subjects were performed between July 26, 1999, and May 17, 2001.
Data Analysis
Mean (± SEM) values for age, FVC (in liters and percent predicted), FEV1 (in liters and percent predicted), log C2, and log C5 were calculated and compared by an unpaired Student t test for independent samples with those from a consecutively chosen, historical control group of 50 healthy, male nonsmokers who had previously undergone identical cough challenge testing during the period between January 2, 1996, and July 15, 1999. All cough challenge studies were performed by the author.
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
The results of this investigation confirm those of previous, smaller studies employing capsaicin5 and citric acid6 as tussive stimuli. To the best of my knowledge, the present study provides the largest and only gender-specific comparison of cough reflex sensitivity between healthy, asymptomatic, current-smokers and nonsmokers. When analyzing cough sensitivity measurements among different populations, it is essential that the comparison be gender-specific, since the cough reflex is significantly more sensitive in women.8 9 A potential limitation of this study is the use of historical rather than contemporaneous control subjects.
The mechanism of diminished cough reflex sensitivity in smokers remains speculative. Perhaps long-term exposure to tobacco smoke desensitizes the cough receptors residing within the airway epithelium. Cough receptor desensitization may explain the lower incidence of angiotensin-converting enzyme inhibitor-induced cough in smokers relative to nonsmokers.14 15 This hypothesis also may explain the interesting observation that cough often transiently increases after smoking cessation.16
Alternatively, long-term tobacco smoke-induced changes in the character of airway mucus may play a role in modulating cough reflex sensitivity. Previous studies17 have shown both a quantitative as well as a qualitative difference in the composition of mucus from asymptomatic smokers, with increased volume and increased mucociliary clearability compared to the mucus of nonsmokers. Enhanced mucus volume may provide a barrier shielding the superficial airway cough receptors from tussive stimuli.
It has been suggested that the nicotine-induced inhibition of C fibers, or the depletion of neuropeptides, within the airways may explain the diminished cough reflex sensitivity in smokers.5 However, earlier work showed that, in humans, inhaled nicotine induces concentration-dependent cough and, in animals, electrophysiologic studies have demonstrated that nicotine excites cough-inducing RARs.18
Another possible explanation of our results is that smokers comprise a select group of individuals with naturally diminished cough reflex sensitivity. Although this theory may seem unlikely, it is quite interesting to note that multiple studies have demonstrated diminished cough sensitivity in persons who enjoy smoking occasionally, compared to regular smokers and nonsmokers.6 19 20
The significance of diminished cough reflex sensitivity in current-smokers is unknown at this time. However, previous studies in different populations have suggested that the suppression of the cough reflex may indeed have important clinical ramifications. For example, a diminished cough reflex has been associated with an increased risk of developing aspiration pneumonia in stroke patients21 and in the elderly.22 Conversely, hypertensive stroke patients treated with angiotensin-converting enzyme inhibitors, drugs that enhance cough reflex sensitivity, have a lower incidence of pneumonia compared with stroke patients treated with other antihypertensive agents.23
In addition to the diminished cough reflex sensitivity demonstrated herein, other factors may contribute to further compromise the effectiveness of cough in current-smokers. For example, studies using radiolabeled aerosols have shown that young, healthy smokers with normal pulmonary function are unable to enhance their rate of mucus clearance by coughing, suggesting an alteration in the mucociliary apparatus.24 The clinical spectrum and significance of long-term tobacco smoke-induced changes in the cough reflex await further elucidation in future studies.
| Footnotes |
|---|
Presented in part at the American Thoracic Society International Conference, Atlanta, GA, May 22, 2002.
Received for publication November 26, 2001. Accepted for publication September 10, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Oshima, Y. Kasuya, Y. Okumura, T. Murakami, and S. Dohi Identification of independent risk factors for fentanyl-induced cough: [L'identification de facteurs de risque independants pour la toux induite par le fentanyl]. Can J Anesth, August 1, 2006; 53(8): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Johansson, E. Millqvist, S. Nordin, and M. Bende Relationship Between Self-Reported Odor Intolerance and Sensitivity to Inhaled Capsaicin: Proposed Definition of Airway Sensory Hyperreactivity and Estimation of Its Prevalence Chest, June 1, 2006; 129(6): 1623 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ebihara, T. Ebihara, T. Okazaki, and H. Sasaki Cigarette Smoking, Cough Reflex, and Respiratory Tract Infection Arch Intern Med, April 11, 2005; 165(7): 814 - 814. [Full Text] [PDF] |
||||
![]() |
B. P. Ponsioen, W. C. J. Hop, N. A. Vermue, P. N. R. Dekhuijzen, and A. M. Bohnen Efficacy of fluticasone on cough: a randomised controlled trial Eur. Respir. J., January 1, 2005; 25(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |